Global Hemostatic Powders and Hemostatic Agents Production, Demand and Key Producers, 2022-2028

Page: 117

Published Date: 29 Sep 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

This report studies the global Hemostatic Powders and Hemostatic Agents demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hemostatic Powders and Hemostatic Agents, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hemostatic Powders and Hemostatic Agents that contribute to its increasing demand across many markets.

The global Hemostatic Powders and Hemostatic Agents market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study
Global Hemostatic Powders and Hemostatic Agents total market, 2017-2028, (USD Million)
Global Hemostatic Powders and Hemostatic Agents total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Hemostatic Powders and Hemostatic Agents total market, key domestic companies and share, (USD Million)
Global Hemostatic Powders and Hemostatic Agents revenue by player and market share 2017-2022, (USD Million)
Global Hemostatic Powders and Hemostatic Agents total market by Type, CAGR, 2017-2028, (USD Million)
Global Hemostatic Powders and Hemostatic Agents total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Hemostatic Powders and Hemostatic Agents market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Medline Industries, Baxter, Pfizer, Zimmer Biomet, McKesson, Integra Life Sciences, Medtronic and CryoLife, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hemostatic Powders and Hemostatic Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Hemostatic Powders and Hemostatic Agents Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Hemostatic Powders and Hemostatic Agents Market, Segmentation by Type
    Microfibrous Collagen
    Chitosan

Global Hemostatic Powders and Hemostatic Agents Market, Segmentation by Application
    Home
    Clinic
    Hospital

Companies Profiled:
    BD
    Medline Industries
    Baxter
    Pfizer
    Zimmer Biomet
    McKesson
    Integra Life Sciences
    Medtronic
    CryoLife
    CSL Behring
    Ethicon
    B Braun Melsungen
    Gelita Medical
    Smith & Nephew
    Teleflex

Key Questions Answered
1. How big is the global Hemostatic Powders and Hemostatic Agents market?
2. What is the demand of the global Hemostatic Powders and Hemostatic Agents market?
3. What is the year over year growth of the global Hemostatic Powders and Hemostatic Agents market?
4. What is the total value of the global Hemostatic Powders and Hemostatic Agents market?
5. Who are the major players in the global Hemostatic Powders and Hemostatic Agents market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Hemostatic Powders and Hemostatic Agents Introduction
    1.2 World Hemostatic Powders and Hemostatic Agents Market Size & Forecast (2017 & 2021 & 2028)
    1.3 World Hemostatic Powders and Hemostatic Agents Total Market by Region
        1.3.1 World Hemostatic Powders and Hemostatic Agents Market Size by Region (2017-2028)
        1.3.2 United States Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
        1.3.3 China Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
        1.3.4 Europe Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
        1.3.5 Japan Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
        1.3.6 South Korea Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
        1.3.7 ASEAN Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
        1.3.8 India Hemostatic Powders and Hemostatic Agents Market Size (2017-2028)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hemostatic Powders and Hemostatic Agents Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hemostatic Powders and Hemostatic Agents Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 World Hemostatic Powders and Hemostatic Agents Companies Competitive Analysis
    2.1 World Hemostatic Powders and Hemostatic Agents Revenue by Player (2017-2022)
    2.2 Industry Rank and Concentration Rate (CR)
        2.2.1 Global Hemostatic Powders and Hemostatic Agents Industry Rank of Major Players
        2.2.2 Global Concentration Ratios (CR4) for Hemostatic Powders and Hemostatic Agents in 2021
        2.2.3 Global Concentration Ratios (CR8) for Hemostatic Powders and Hemostatic Agents in 2021
    2.3 Hemostatic Powders and Hemostatic Agents Company Evaluation Quadrant
    2.4 Hemostatic Powders and Hemostatic Agents Market: Overall Company Footprint Analysis
        2.4.1 Hemostatic Powders and Hemostatic Agents Market: Region Footprint
        2.4.2 Hemostatic Powders and Hemostatic Agents Market: Company Product Type Footprint
        2.4.3 Hemostatic Powders and Hemostatic Agents Market: Company Product Application Footprint
    2.5 Competitive Environment
        2.5.1 Historical Structure of the Industry
        2.5.2 Barriers of Market Entry
        2.5.3 Factors of Competition
    2.6 Mergers, Acquisitions Activity

3 United States VS China VS Rest of the World
    3.1 United States VS China: Hemostatic Powders and Hemostatic Agents Market Comparison
        3.1.1 United States VS China: Hemostatic Powders and Hemostatic Agents Market Size Comparison (2017 & 2021 & 2028)
        3.1.2 United States VS China: Hemostatic Powders and Hemostatic Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
    3.2 United States Hemostatic Powders and Hemostatic Agents Major Players and Market Share, 2017-2022
        3.2.1 Major Players of Hemostatic Powders and Hemostatic Agents in United States, Headquarters (States, Country)
        3.2.2 United States Hemostatic Powders and Hemostatic Agents Revenue by Domestic Player, (2017-2022)
    3.3 China Hemostatic Powders and Hemostatic Agents Major Players and Market Share, 2017-2022
        3.3.1 Major Players of Hemostatic Powders and Hemostatic Agents in China, Headquarters (Province, Country)
        3.3.2 China Hemostatic Powders and Hemostatic Agents Revenue by Domestic Player, (2017-2022)
    3.4 Rest of World Hemostatic Powders and Hemostatic Agents Major Players and Market Share, 2017-2022
        3.4.1 Major Players of Hemostatic Powders and Hemostatic Agents in Rest of World, Headquarters (State, Country)
        3.4.2 Rest of World Hemostatic Powders and Hemostatic Agents Revenue by Domestic Player, (2017-2022)

4 Market Analysis by Type
    4.1 World Hemostatic Powders and Hemostatic Agents Market Size Overview by Type: 2017 VS 2021 VS 2028
    4.2 Segment Introduction by Type
        4.2.1 Microfibrous Collagen
        4.2.2 Chitosan
    4.3 Market Segment by Type
        4.3.1 World Hemostatic Powders and Hemostatic Agents Market Size by Type (2017-2022)
        4.3.2 World Hemostatic Powders and Hemostatic Agents Market Size by Type (2023-2028)
        4.3.3 World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Type (2017-2028)

5 Market Analysis by Application
    5.1 World Hemostatic Powders and Hemostatic Agents Market Size Overview by Application: 2017 VS 2021 VS 2028
    5.2 Segment Introduction by Application
        5.2.1 Home
        5.2.2 Clinic
        5.2.3 Hospital
    5.3 Market Segment by Application
        5.3.1 World Hemostatic Powders and Hemostatic Agents Market Size by Application (2017-2022)
        5.3.2 World Hemostatic Powders and Hemostatic Agents Market Size by Application (2023-2028)
        5.3.3 World Hemostatic Powders and Hemostatic Agents Market Size by Application (2017-2028)

6 Company Profiles
    6.1 BD
        6.1.1 BD Details
        6.1.2 BD Major Business
        6.1.3 BD Hemostatic Powders and Hemostatic Agents Product and Services
        6.1.4 BD Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.1.5 BD Recent Developments/Updates
        6.1.6 BD Competitive Strengths & Weaknesses
    6.2 Medline Industries
        6.2.1 Medline Industries Details
        6.2.2 Medline Industries Major Business
        6.2.3 Medline Industries Hemostatic Powders and Hemostatic Agents Product and Services
        6.2.4 Medline Industries Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.2.5 Medline Industries Recent Developments/Updates
        6.2.6 Medline Industries Competitive Strengths & Weaknesses
    6.3 Baxter
        6.3.1 Baxter Details
        6.3.2 Baxter Major Business
        6.3.3 Baxter Hemostatic Powders and Hemostatic Agents Product and Services
        6.3.4 Baxter Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.3.5 Baxter Recent Developments/Updates
        6.3.6 Baxter Competitive Strengths & Weaknesses
    6.4 Pfizer
        6.4.1 Pfizer Details
        6.4.2 Pfizer Major Business
        6.4.3 Pfizer Hemostatic Powders and Hemostatic Agents Product and Services
        6.4.4 Pfizer Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.4.5 Pfizer Recent Developments/Updates
        6.4.6 Pfizer Competitive Strengths & Weaknesses
    6.5 Zimmer Biomet
        6.5.1 Zimmer Biomet Details
        6.5.2 Zimmer Biomet Major Business
        6.5.3 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Product and Services
        6.5.4 Zimmer Biomet Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.5.5 Zimmer Biomet Recent Developments/Updates
        6.5.6 Zimmer Biomet Competitive Strengths & Weaknesses
    6.6 McKesson
        6.6.1 McKesson Details
        6.6.2 McKesson Major Business
        6.6.3 McKesson Hemostatic Powders and Hemostatic Agents Product and Services
        6.6.4 McKesson Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.6.5 McKesson Recent Developments/Updates
        6.6.6 McKesson Competitive Strengths & Weaknesses
    6.7 Integra Life Sciences
        6.7.1 Integra Life Sciences Details
        6.7.2 Integra Life Sciences Major Business
        6.7.3 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Product and Services
        6.7.4 Integra Life Sciences Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.7.5 Integra Life Sciences Recent Developments/Updates
        6.7.6 Integra Life Sciences Competitive Strengths & Weaknesses
    6.8 Medtronic
        6.8.1 Medtronic Details
        6.8.2 Medtronic Major Business
        6.8.3 Medtronic Hemostatic Powders and Hemostatic Agents Product and Services
        6.8.4 Medtronic Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.8.5 Medtronic Recent Developments/Updates
        6.8.6 Medtronic Competitive Strengths & Weaknesses
    6.9 CryoLife
        6.9.1 CryoLife Details
        6.9.2 CryoLife Major Business
        6.9.3 CryoLife Hemostatic Powders and Hemostatic Agents Product and Services
        6.9.4 CryoLife Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.9.5 CryoLife Recent Developments/Updates
        6.9.6 CryoLife Competitive Strengths & Weaknesses
    6.10 CSL Behring
        6.10.1 CSL Behring Details
        6.10.2 CSL Behring Major Business
        6.10.3 CSL Behring Hemostatic Powders and Hemostatic Agents Product and Services
        6.10.4 CSL Behring Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.10.5 CSL Behring Recent Developments/Updates
        6.10.6 CSL Behring Competitive Strengths & Weaknesses
    6.11 Ethicon
        6.11.1 Ethicon Details
        6.11.2 Ethicon Major Business
        6.11.3 Ethicon Hemostatic Powders and Hemostatic Agents Product and Services
        6.11.4 Ethicon Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.11.5 Ethicon Recent Developments/Updates
        6.11.6 Ethicon Competitive Strengths & Weaknesses
    6.12 B Braun Melsungen
        6.12.1 B Braun Melsungen Details
        6.12.2 B Braun Melsungen Major Business
        6.12.3 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Product and Services
        6.12.4 B Braun Melsungen Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.12.5 B Braun Melsungen Recent Developments/Updates
        6.12.6 B Braun Melsungen Competitive Strengths & Weaknesses
    6.13 Gelita Medical
        6.13.1 Gelita Medical Details
        6.13.2 Gelita Medical Major Business
        6.13.3 Gelita Medical Hemostatic Powders and Hemostatic Agents Product and Services
        6.13.4 Gelita Medical Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.13.5 Gelita Medical Recent Developments/Updates
        6.13.6 Gelita Medical Competitive Strengths & Weaknesses
    6.14 Smith & Nephew
        6.14.1 Smith & Nephew Details
        6.14.2 Smith & Nephew Major Business
        6.14.3 Smith & Nephew Hemostatic Powders and Hemostatic Agents Product and Services
        6.14.4 Smith & Nephew Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.14.5 Smith & Nephew Recent Developments/Updates
        6.14.6 Smith & Nephew Competitive Strengths & Weaknesses
    6.15 Teleflex
        6.15.1 Teleflex Details
        6.15.2 Teleflex Major Business
        6.15.3 Teleflex Hemostatic Powders and Hemostatic Agents Product and Services
        6.15.4 Teleflex Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022)
        6.15.5 Teleflex Recent Developments/Updates
        6.15.6 Teleflex Competitive Strengths & Weaknesses

7 Raw Material and Industry Chain
    7.1 Raw Material of Hemostatic Powders and Hemostatic Agents and Key Manufacturers
    7.2 Hemostatic Powders and Hemostatic Agents Manufacturing Costs
    7.3 Hemostatic Powders and Hemostatic Agents Production Process
    7.4 Hemostatic Powders and Hemostatic Agents Industrial Chain

8 Distribution Channel Analysis
    8.1 Distribution Channel Breakdown for Hemostatic Powders and Hemostatic Agents Shipments (%): 2017-2028
        8.1.1 Direct Channel
        8.1.2 Indirect Channel
    8.2 Hemostatic Powders and Hemostatic Agents Typical Distributors
    8.3 Hemostatic Powders and Hemostatic Agents Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Hemostatic Powders and Hemostatic Agents Market Size by Region (2017, 2022 and 2028) & (USD Million)
    Table 2. World Hemostatic Powders and Hemostatic Agents Market Size by Region (2017-2022) & (USD Million)
    Table 3. World Hemostatic Powders and Hemostatic Agents Market Size by Region (2023-2028) & (USD Million)
    Table 4. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Region (2017-2022)
    Table 5. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Region (2023-2028)
    Table 6. Major Market Trends
    Table 7. World Hemostatic Powders and Hemostatic Agents Revenue by Player (2017-2022) & (USD Million)
    Table 8. Revenue Market Share of Key Hemostatic Powders and Hemostatic Agents Players in 2021
    Table 9. World Hemostatic Powders and Hemostatic Agents Industry Rank of Major Player, Based on Revenue in 2021
    Table 10. Global Hemostatic Powders and Hemostatic Agents Company Evaluation Quadrant
    Table 11. Head Office of Key Hemostatic Powders and Hemostatic Agents Player
    Table 12. Hemostatic Powders and Hemostatic Agents Market: Company Product Type Footprint
    Table 13. Hemostatic Powders and Hemostatic Agents Market: Company Product Application Footprint
    Table 14. Hemostatic Powders and Hemostatic Agents Mergers & Acquisitions Activity
    Table 15. United States VS China Hemostatic Powders and Hemostatic Agents Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
    Table 16. Major Player of Hemostatic Powders and Hemostatic Agents in United States, Headquarters (States, Country)
    Table 17. United States Hemostatic Powders and Hemostatic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
    Table 18. United States Hemostatic Powders and Hemostatic Agents Revenue Market Share by Domestic Player, (2017-2022)
    Table 19. Major Player of Hemostatic Powders and Hemostatic Agents in China, Company Headquarters (Province, Country)
    Table 20. China Hemostatic Powders and Hemostatic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
    Table 21. China Hemostatic Powders and Hemostatic Agents Revenue Market Share by Domestic Player, (2017-2022)
    Table 22. Major Player of Hemostatic Powders and Hemostatic Agents in Rest of World, Company Headquarters (State, Country)
    Table 23. Rest of World Hemostatic Powders and Hemostatic Agents Revenue by Domestic Player, (2017-2022) & (USD Million)
    Table 24. Rest of World Hemostatic Powders and Hemostatic Agents Revenue Market Share by Domestic Player, (2017-2022)
    Table 25. World Hemostatic Powders and Hemostatic Agents Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 26. World Hemostatic Powders and Hemostatic Agents Revenue by Type (2017-2022) & (USD Million)
    Table 27. World Hemostatic Powders and Hemostatic Agents Revenue by Type (2023-2028) & (USD Million)
    Table 28. World Hemostatic Powders and Hemostatic Agents Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 29. World Hemostatic Powders and Hemostatic Agents Revenue by Application (2017-2022) & (USD Million)
    Table 30. World Hemostatic Powders and Hemostatic Agents Revenue by Application (2023-2028) & (USD Million)
    Table 31. BD Basic Information, Manufacturing Base and Competitors
    Table 32. BD Major Business
    Table 33. BD Hemostatic Powders and Hemostatic Agents Product and Services
    Table 34. BD Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 35. BD Recent Developments/Updates
    Table 36. BD Competitive Strengths & Weaknesses
    Table 37. Medline Industries Basic Information, Manufacturing Base and Competitors
    Table 38. Medline Industries Major Business
    Table 39. Medline Industries Hemostatic Powders and Hemostatic Agents Product and Services
    Table 40. Medline Industries Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 41. Medline Industries Recent Developments/Updates
    Table 42. Medline Industries Competitive Strengths & Weaknesses
    Table 43. Baxter Basic Information, Manufacturing Base and Competitors
    Table 44. Baxter Major Business
    Table 45. Baxter Hemostatic Powders and Hemostatic Agents Product and Services
    Table 46. Baxter Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 47. Baxter Recent Developments/Updates
    Table 48. Baxter Competitive Strengths & Weaknesses
    Table 49. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 50. Pfizer Major Business
    Table 51. Pfizer Hemostatic Powders and Hemostatic Agents Product and Services
    Table 52. Pfizer Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 53. Pfizer Recent Developments/Updates
    Table 54. Pfizer Competitive Strengths & Weaknesses
    Table 55. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
    Table 56. Zimmer Biomet Major Business
    Table 57. Zimmer Biomet Hemostatic Powders and Hemostatic Agents Product and Services
    Table 58. Zimmer Biomet Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 59. Zimmer Biomet Recent Developments/Updates
    Table 60. Zimmer Biomet Competitive Strengths & Weaknesses
    Table 61. McKesson Basic Information, Manufacturing Base and Competitors
    Table 62. McKesson Major Business
    Table 63. McKesson Hemostatic Powders and Hemostatic Agents Product and Services
    Table 64. McKesson Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 65. McKesson Recent Developments/Updates
    Table 66. McKesson Competitive Strengths & Weaknesses
    Table 67. Integra Life Sciences Basic Information, Manufacturing Base and Competitors
    Table 68. Integra Life Sciences Major Business
    Table 69. Integra Life Sciences Hemostatic Powders and Hemostatic Agents Product and Services
    Table 70. Integra Life Sciences Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 71. Integra Life Sciences Recent Developments/Updates
    Table 72. Integra Life Sciences Competitive Strengths & Weaknesses
    Table 73. Medtronic Basic Information, Manufacturing Base and Competitors
    Table 74. Medtronic Major Business
    Table 75. Medtronic Hemostatic Powders and Hemostatic Agents Product and Services
    Table 76. Medtronic Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 77. Medtronic Recent Developments/Updates
    Table 78. Medtronic Competitive Strengths & Weaknesses
    Table 79. CryoLife Basic Information, Manufacturing Base and Competitors
    Table 80. CryoLife Major Business
    Table 81. CryoLife Hemostatic Powders and Hemostatic Agents Product and Services
    Table 82. CryoLife Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 83. CryoLife Recent Developments/Updates
    Table 84. CryoLife Competitive Strengths & Weaknesses
    Table 85. CSL Behring Basic Information, Manufacturing Base and Competitors
    Table 86. CSL Behring Major Business
    Table 87. CSL Behring Hemostatic Powders and Hemostatic Agents Product and Services
    Table 88. CSL Behring Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 89. CSL Behring Recent Developments/Updates
    Table 90. CSL Behring Competitive Strengths & Weaknesses
    Table 91. Ethicon Basic Information, Manufacturing Base and Competitors
    Table 92. Ethicon Major Business
    Table 93. Ethicon Hemostatic Powders and Hemostatic Agents Product and Services
    Table 94. Ethicon Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 95. Ethicon Recent Developments/Updates
    Table 96. Ethicon Competitive Strengths & Weaknesses
    Table 97. B Braun Melsungen Basic Information, Manufacturing Base and Competitors
    Table 98. B Braun Melsungen Major Business
    Table 99. B Braun Melsungen Hemostatic Powders and Hemostatic Agents Product and Services
    Table 100. B Braun Melsungen Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 101. B Braun Melsungen Recent Developments/Updates
    Table 102. B Braun Melsungen Competitive Strengths & Weaknesses
    Table 103. Gelita Medical Basic Information, Manufacturing Base and Competitors
    Table 104. Gelita Medical Major Business
    Table 105. Gelita Medical Hemostatic Powders and Hemostatic Agents Product and Services
    Table 106. Gelita Medical Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 107. Gelita Medical Recent Developments/Updates
    Table 108. Gelita Medical Competitive Strengths & Weaknesses
    Table 109. Smith & Nephew Basic Information, Manufacturing Base and Competitors
    Table 110. Smith & Nephew Major Business
    Table 111. Smith & Nephew Hemostatic Powders and Hemostatic Agents Product and Services
    Table 112. Smith & Nephew Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 113. Smith & Nephew Recent Developments/Updates
    Table 114. Teleflex Basic Information, Manufacturing Base and Competitors
    Table 115. Teleflex Major Business
    Table 116. Teleflex Hemostatic Powders and Hemostatic Agents Product and Services
    Table 117. Teleflex Hemostatic Powders and Hemostatic Agents Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
    Table 118. Hemostatic Powders and Hemostatic Agents Raw Material
    Table 119. Key Manufacturers of Hemostatic Powders and Hemostatic Agents Raw Materials
    Table 120. Hemostatic Powders and Hemostatic Agents Typical Distributors
    Table 121. Hemostatic Powders and Hemostatic Agents Typical Customers
List of Figure
    Figure 1. Hemostatic Powders and Hemostatic Agents Picture
    Figure 2. World Hemostatic Powders and Hemostatic Agents Total Market Size: 2017 & 2021 & 2028, (USD Million)
    Figure 3. World Hemostatic Powders and Hemostatic Agents Total Market Size (2017-2028) & (USD Million)
    Figure 4. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Region (2017-2028)
    Figure 5. United States Hemostatic Powders and Hemostatic Agents Market Size (2017-2028) & (USD Million)
    Figure 6. China Hemostatic Powders and Hemostatic Agents Market Size (2017-2028) & (USD Million)
    Figure 7. Europe Hemostatic Powders and Hemostatic Agents Market Size (2017-2028) & (USD Million)
    Figure 8. Japan Hemostatic Powders and Hemostatic Agents Market Size (2017-2028) & (USD Million)
    Figure 9. South Korea Hemostatic Powders and Hemostatic Agents Market Size (2017-2028) & (USD Million)
    Figure 10. ASEAN Hemostatic Powders and Hemostatic Agents Market Size (2017-2028) & (USD Million)
    Figure 11. India Hemostatic Powders and Hemostatic Agents Market Size (2017-2028) & (USD Million)
    Figure 12. Hemostatic Powders and Hemostatic Agents Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. Producer Shipments of Hemostatic Powders and Hemostatic Agents by Player Revenue ($MM) and Market Share (%): 2021
    Figure 15. Global Four-firm Concentration Ratios (CR4) for Hemostatic Powders and Hemostatic Agents Markets in 2021
    Figure 16. Global Four-firm Concentration Ratios (CR8) for Hemostatic Powders and Hemostatic Agents Markets in 2021
    Figure 17. United States VS China: Hemostatic Powders and Hemostatic Agents Market Size Market Share Comparison (2017 & 2021 & 2028)
    Figure 18. World Hemostatic Powders and Hemostatic Agents Market Size by Type, (USD Million), 2017 & 2021 & 2028
    Figure 19. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Type in 2021
    Figure 20. Microfibrous Collagen
    Figure 21. Chitosan
    Figure 22. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Type (2017-2028)
    Figure 23. World Hemostatic Powders and Hemostatic Agents Market Size by Application, (USD Million), 2017 & 2021 & 2028
    Figure 24. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Application in 2021
    Figure 25. Home
    Figure 26. Clinic
    Figure 27. Hospital
    Figure 28. World Hemostatic Powders and Hemostatic Agents Market Size Market Share by Application (2017-2028)
    Figure 29. Manufacturing Cost Structure Analysis of Hemostatic Powders and Hemostatic Agents in 2021
    Figure 30. Manufacturing Process Analysis of Hemostatic Powders and Hemostatic Agents
    Figure 31. Hemostatic Powders and Hemostatic Agents Industrial Chain
    Figure 32. Distribution Channel Breakdown for Hemostatic Powders and Hemostatic Agents Shipments (%): 2017-2028
    Figure 33. Direct Channel Pros & Cons
    Figure 34. Indirect Channel Pros & Cons
    Figure 35. Methodology
    Figure 36. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

BD
Medline Industries
Baxter
Pfizer
Zimmer Biomet
McKesson
Integra Life Sciences
Medtronic
CryoLife
CSL Behring
Ethicon
B Braun Melsungen
Gelita Medical
Smith & Nephew
Teleflex

Product Tags

hemostatic powders hemostatic agents production demand producers

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>